On September 28, 2020 Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, reported that management will participate in two upcoming virtual conferences (Press release, Bellicum Pharmaceuticals, SEP 28, 2020, View Source [SID1234567679]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:

Jefferies Cell Therapy Virtual Summit
Date/Time: Monday, October 5, 2020 at 11:30 a.m. EDT
Format: Fireside chat

2020 Virtual Cell & Gene Meeting on the Mesa
Date: Monday, October 12, 2020 – Friday, October 16, 2020
Format: Prerecorded company presentation will be available for registered attendees to view on-demand throughout the entirety of the conference. Please visit www.meetingonthemesa.com for full information including registration.

A live webcast of the fireside chat at the Jefferies Cell Therapy Summit may be accessed from the Events & Presentation section of the Bellicum website. An archived version of the Jefferies fireside chat will be available for replay following the event.